Assessment of efficacy of topical dutasteride lotion in the treatment of androgenetic alopecia.

CUTIS Academy of Cutaneous Sciences0 个研究点目标入组 10 人开始时间: 待定最近更新: 2022年11月21日

试验速览

暂无简介。

•1.All patients aged 18 - 60 years diagnosed with mild to moderate androgenetic alopecia attending the OPD (Norwood Hamilton scale III to V and Ludwig scale II and III)
•2.Patients willing to refrain from other forms of treatment including other topical medications, oral medications for hair loss (other than the nutritional supplement prescribed), laser treatments, injectable treatments and hair transplantation for the duration of the study.
•3.Women of child-bearing age with FPHL, who are not planning pregnancy in the next 2 years and are willing to give consent stating the same.
•4.Patients who are willing to appear for regular follow ups and follow the prescribed treatment regularly.

•1.Patients suffering from other causes of non-cicatricial alopecia or cicatricial alopecia.
•2.Patients suffering from infectious, auto-immune, or other disorders affecting skin of scalp.
•3.Patients already on drugs that would affect the hair cycle in past 3 months.
•4.Patients suffering from severe AGA (Norwood Hamilton scale VI to VII).
•5.Women of child-bearing age planning pregnancy in the next 2 years.
•6.Patients known to be allergic to any of the components of the study medications.
•7.Patients with known malignancy or those on chemotherapy.
•8.Refusal to participate in the study.

发起方